The "U.S. Insulin Delivery Devices Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034" ...

Inhaled insulin shows safety and high treatment satisfaction in youth with type 1 diabetes over 26 weeks but does not meet ...

Automated insulin delivery systems — a continuous glucose monitor, insulin pump, and algorithm — enable athletes to manage ...

Modular Medical ( ($MODD) ) has provided an update. On December 10, 2025, Modular Medical, Inc. entered into an Underwriting Agreement with ...

The "U.S. Insulin Pen Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034" report has been ...

A weight loss drug dubbed the "triple G" drug for its effectiveness in mimicking three hunger-regulating hormones showed ...

The issue affected about 3 million Libre 3 and Libre 3 Plus sensors in the U.S. and globally Abbott has received reports of 736 serious health problems (57 in the U.S.) and seven deaths (none in the U ...

In connection with the offering, Modular Medical has granted the underwriter a 30-day option to purchase up to an additional 15% of common shares and/or warrants at the public offering price, less ...

Members of the Company’s management team will host in-person meetings in San Francisco from January 12, 2026 through January 14, 2026 to discuss topline fourth quarter 2025 results. The Company ...

Health care company Abbott is recalling approximately three million blood glucose sensors as there has been a fault found in ...

Health Canada is asking diabetes patients to check if their glucose monitor is subject to an international recall that has ...

About 3 million glucose monitoring sensors were potentially affected by a production error that caused incorrect low glucose readings.